Based on data from CREATE-X/JBCRG-04, would you consider adjuvant capecitabine in breast cancer patients treated with neoadjuvant chemotherapy who do not achieve a pCR?  

Masuda et al. NEJM 2017

If so, how do you sequence it with adjuvant radiotherapy?



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at University of Pittsburgh School of Medicine
Now that the publication has come out (18 months l...
Medical Oncologist at Kettering Cancer Center
@Adam, in 2023, do you still use capecitabine in T...
Medical Oncologist at University of Pittsburgh School of Medicine
@Alejandro R. Calvo This is a great question. CRE...
Sign in or Register to read more